Product Overview
AOD‑9604 – Research‑Grade hGH‑Derived Fragment for Metabolic and Lipolytic Pathway Investigation
Synonyms: hGH Fragment 176–191; AOD9604
CAS Number: 221231‑10‑3
Sequence: Tyr‑Leu‑Arg‑Ile‑Val‑Gln‑Cys‑Arg‑Ser‑Val‑Gly‑Phe
Molecular Weight: Approx. 1,814 Da
Form: Lyophilised powder
Purity: ≥98% (HPLC)
Use: For laboratory research only. Not for human or veterinary use.
Overview
AOD‑9604 is a synthetic peptide fragment derived from the C‑terminal region of human growth hormone (hGH). It is widely used in research examining metabolic regulation, adipocyte biology, and lipolytic signalling pathways.
Scientific investigations focus on its potential involvement in lipid metabolism, energy utilisation, and adipose‑tissue‑specific biochemical processes in controlled laboratory models.
Its selective activity and structural stability make it suitable for in vitro and non‑human in vivo studies exploring metabolic and endocrine‑related mechanisms.
Mechanistic Insights
Preclinical research has examined AOD‑9604 in relation to several metabolic pathways:
• Lipolytic Signalling – Studied for its potential to influence fat‑cell metabolism and lipid mobilisation in non‑human models.
• Adipocyte Regulation – Investigated for its effects on adipocyte differentiation and lipid turnover.
• Metabolic Pathways – Explored for its involvement in energy‑utilisation processes independent of full‑length hGH activity.
• Endocrine‑Related Mechanisms – Evaluated for its selective interaction with pathways associated with fat metabolism rather than growth‑related signalling.
These findings are derived from published scientific literature and do not imply any therapeutic or physiological effects in humans.
Research Context
AOD‑9604 is utilised exclusively within controlled laboratory environments for:
• Studies involving adipocyte biology and lipid metabolism
• Investigations into metabolic regulation and energy‑balance pathways
• Experimental models assessing lipolytic responses
• Comparative research involving hGH‑derived fragments or metabolic peptides
This material is not intended for therapeutic, diagnostic, or clinical use.
Packaging & Storage
• Supplied as a sterile‑filtered, lyophilised peptide
• Store at –20°C, protected from light and moisture
• Reconstitute under sterile laboratory conditions using bacteriostatic water or a suitable research‑grade diluent
• Store reconstituted solutions at 2–8°C and use according to institutional guidelines
Additional solubility and technical data are available to qualified research institutions upon request.
Compliance Notice
This product is intended solely for laboratory research purposes.
It is not approved for human or veterinary administration and must not be incorporated into food, cosmetics, pharmaceuticals, or any product intended for biological exposure.
All information provided is for scientific and educational reference only. Researchers are responsible for ensuring compliance with all applicable regulations, institutional policies, and safety standards.
